# Differential activation of monocytes and PMNs in orofacial granulomatosis patients induced by bacterial and non-bacterial stimuli

**Authors:** Francesco Palestra, Luca Modestino, Annagioia Ventrici, Arianna Monteforte, Gina Memoli, Anne Lise Ferrara, Leonardo Cristinziano, Remo Poto, Francesca Wanda Rossi, Gilda Varricchi, Amato De Paulis, Gianni Marone, Giuseppe Spadaro, Angelica Petraroli, Stefania Loffredo, Maria Rosaria Galdiero

PMC · DOI: 10.3389/fimmu.2025.1522495 · 2025-05-06

## TL;DR

This study explores immune cell activation in orofacial granulomatosis patients in response to bacterial and non-bacterial stimuli.

## Contribution

The study reveals distinct activation patterns of monocytes and PMNs in OFG patients compared to healthy donors.

## Key findings

- OFG-derived monocytes release more pro-inflammatory cytokines and less IL-10 and IFN-γ compared to healthy donors.
- OFG-derived PMNs show increased TNF-α, MPO, ROS production, and activation markers compared to healthy donors.
- OFG patients have elevated serum levels of MMP-9, MPO, TNF-α, and neutrophil extracellular trap biomarkers.

## Abstract

Orofacial Granulomatosis (OFG) is a rare chronic inflammatory disorder characterized by persistent or recurrent swelling of the lips and oral mucosa, often accompanied by granulomatous inflammation in the orofacial region with limited effective treatment options available. Emerging evidence suggests an immune dysregulation in the development and progression of OFG. Immune cells, including monocytes and neutrophils (PMNs), are involved in autoimmune and inflammatory diseases by releasing pro-inflammatory and immunomodulatory molecules.

Considering that microbial agents have been suggested as potential triggers for OFG, in this study we evaluated the effect of LPS, fMLP and PMA on the activation of monocytes and PMNs purified by 11 OFG patients and 11 sex-and age-matched healthy donors (HDs).

Upon stimulation, OFG-derived monocytes displayed a higher release of pro-inflammatory cytokines (CXCL8/IL-8, IL-6, TNF-α, IL-33) compared to HDs. Conversely, OFG-derived monocytes showed a lower release of IL-10, IFN-γ compared to HDs. Upon stimulation, peripheral PMNs from OFG patients released large amounts of TNF-α and MPO compared to HDs. In addition, OFG-derived PMNs showed high percentages of activated PMNs (CD62L-) and increased ROS production compared to HDs. Compared to HDs, OFG patients presented higher serum levels of MMP-9, MPO and TNF-α, together with MPO-DNA complexes and citrullinated histone H3 (CitH3) (two biomarkers for neutrophil extracellular traps).

These preliminary data suggest that in presence of various stimuli, monocytes and PMNs of OFG patients displayed an activated phenotype compared to HDs. Unraveling the interplay between bacterial triggers and immune cell function in OFG will be necessary to elucidate mechanisms driving this complex disease and identify novel therapeutic targets for improved management of OFG patients.

## Linked entities

- **Proteins:** IL6 (interleukin 6), TNF (tumor necrosis factor), IL33 (interleukin 33), IL10 (interleukin 10), IFNG (interferon gamma), MPO (myeloperoxidase), MMP9 (matrix metallopeptidase 9), SELL (selectin L), ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase)
- **Chemicals:** fMLP (PubChem CID 443295), PMA (PubChem CID 171116383)
- **Diseases:** inflammatory disorder (MONDO:0021166)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, SELL (selectin L) [NCBI Gene 6402] {aka CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, MPO (myeloperoxidase) [NCBI Gene 4353], IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}
- **Diseases:** OFG (MESH:D051261), swelling (MESH:D004487), granulomatous inflammation (MESH:D007249), autoimmune and inflammatory diseases (MESH:D001327)
- **Chemicals:** CitH3 (-), LPS (MESH:D008070), fMLP (MESH:D009240)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12088978/full.md

---
Source: https://tomesphere.com/paper/PMC12088978